
    
      This study will be a single dose part randomised cross over study with up to 6 study periods.
      ODM-203 may be dosed using a variety of different conditions with respect to food depending
      on emerging data. The impact of changing the presentation of ODM-203 may also be assessed to
      determine the PK of alternative formulations and identify appropriate drug formulations for
      further development.
    
  